<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04691037</url>
  </required_header>
  <id_info>
    <org_study_id>TJCHCCTA-01</org_study_id>
    <nct_id>NCT04691037</nct_id>
  </id_info>
  <brief_title>CCTA Improves Clinical Management of Stable Chest Pain</brief_title>
  <acronym>CICM-SCP</acronym>
  <official_title>Improving the Clinical Management of Stable Chest Pain Based on Imaging: a Registry of Computed Tomography Coronary Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Chest Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator aims to prospectively enroll patients who were referred for coronary&#xD;
      computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP)&#xD;
      suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according&#xD;
      to established guidelines and local institutional protocols. The imaging data were evaluated&#xD;
      using different image post-processing software to comprehensively analyse anatomical,&#xD;
      functional and histological information of coronary. This study will determine if CCTA-based&#xD;
      imaging evaluation can provide more informaton to improve clinical management for SCP,&#xD;
      including fewer MACE and better decision-making of downstream investigations and therapeutic&#xD;
      interventions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">January 1, 2030</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiovascular events</measure>
    <time_frame>3 years</time_frame>
    <description>Cardiac death and myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Invasive coronary angiography</measure>
    <time_frame>3 years</time_frame>
    <description>Invasive coronary angiography occurred at follow-up after CCTA, attributed to CCTA results or unplanned.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication prescription</measure>
    <time_frame>3 years</time_frame>
    <description>Change for medication prescription of antiplatelet agents, anti-ischemic drugs, lipid-lowering agents, angiotensin-converting enzyme inhibition and so on, attributed to CCTA results or unplanned,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary revascularization</measure>
    <time_frame>3 years</time_frame>
    <description>PTCA, PCI or CABG occurred at follow-up after CCTA, attributed to CCTA results or unplanned.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50000</enrollment>
  <condition>Coronary Computed Tomography Angiography</condition>
  <condition>Stable Chest Pain</condition>
  <condition>Optimal Medical Therapy</condition>
  <condition>Invasive Coronary Angiography</condition>
  <condition>Revascularization</condition>
  <condition>Major Adverse Cardiovascular Events</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>CCTA</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CCTA</intervention_name>
    <description>All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary.</description>
    <arm_group_label>CCTA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were referred for CCTA for the assessment of SCP suspected of CAD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  symptomatic patients with SCP suspected of obstructive CAD.&#xD;
&#xD;
          -  referred for CCTA for the assessment of SCP.&#xD;
&#xD;
          -  â‰¥18 years of age.&#xD;
&#xD;
          -  signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute coronary syndromes,&#xD;
&#xD;
          -  previous CAD or coronary revascularization&#xD;
&#xD;
          -  nonsinus rhythm&#xD;
&#xD;
          -  cardiomyopathy, valvular disease, congenital heart disease or left cardiac&#xD;
             insufficiency because of other reasons&#xD;
&#xD;
          -  missing data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jia Zhou</last_name>
    <phone>+8615522485560</phone>
    <email>zhoujiawenzhang@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Chaoyang Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yahang Tan</last_name>
      <email>tanyahangwenzhang@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Chest Hospital</name>
      <address>
        <city>Tianjin</city>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Zhou</last_name>
      <phone>+15522485560</phone>
      <email>zhoujiawenzhang@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 29, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Chest Hospital</investigator_affiliation>
    <investigator_full_name>Zhou Jia</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

